Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

VJOncology

Microsoft brings machine learning to genetics collaboration

Will work with Adaptive Biotechnologies on the human immune system

The ‘Million Hour Challenge’

AstraZeneca employees save two million hours through simplification

dengue fever mosquito

Takeda gets FDA fast-track status for Zika vaccine

The phase I candidate also has the backing of US federal funding body BARDA

Roche Basel Switzerland

Roche wins CHMP backing for Hemlibra

Haemophilia A treatment on course for European approval

- PMLiVE

EMA’s Amsterdam home will not be ready in time

Staff will initially move to a temporary building in the city after Brexit

- PMLiVE

Sobi names Holly May VP of sales and marketing, US

She will work with the biopharma’s commercial and patient access teams

Professor Carole Longson moves from NICE to the ABPI

She joins the UK pharma body as its chief scientific officer

Simplifying HCP access to digital information

New industry-standards group launched

Fresh thinking at Porterhouse Medical Group

Fresh thinking for the Porterhouse Medical Group

As we embrace 2018, the Porterhouse Medical Group is excited by the potential of our latest subsidiary Porterhouse Insights, a global strategic research, insight and evidence consultancy. The new company...

Porterhouse Medical Group

- PMLiVE

CHMP hands Santhera second ‘no’ in Duchenne muscular dystrophy

Swiss biopharma says it will re-file Raxone for the licence extension

Sanofi reception

Ablynx spurns Novo Nordisk and cuts €3.9bn deal with Sanofi

The offer comes at a 110% premium on the Belgian biopharma’s share price

AstraZeneca AZ

AZ’s COPD triple data sets up market clash with GSK

KRONOS trial showed significant improvements in lung function tests over two-drug combos

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links